Molecular mechanisms of amisulpride- and risperidone-induced hPRL in patients with psychiatric disorders: an integrated approach combining network pharmacology and molecular docking.

Chen C, Liu Q, Su X, Li WQ

Open source

DOI
10.1016/j.pnpbp.2026.111974
Published
2026 Oct 2
Container
Progress in neuro-psychopharmacology & biological psychiatry
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.pnpbp.2026.111974,
  title = {Molecular mechanisms of amisulpride- and risperidone-induced hPRL in patients with psychiatric disorders: an integrated approach combining network pharmacology and molecular docking.},
  author = {Chen C and Liu Q and Su X and Li WQ},
  year = {2026},
  journal = {Progress in neuro-psychopharmacology \& biological psychiatry},
  doi = {10.1016/j.pnpbp.2026.111974},
  url = {https://doi.org/10.1016/j.pnpbp.2026.111974}
}

RIS

TY  - JOUR
TI  - Molecular mechanisms of amisulpride- and risperidone-induced hPRL in patients with psychiatric disorders: an integrated approach combining network pharmacology and molecular docking.
AU  - Chen C
AU  - Liu Q
AU  - Su X
AU  - Li WQ
PY  - 2026
JO  - Progress in neuro-psychopharmacology & biological psychiatry
DO  - 10.1016/j.pnpbp.2026.111974
UR  - https://doi.org/10.1016/j.pnpbp.2026.111974
ER  - 

APA

C, C., Q, L., X, S., & WQ, L. (2026). Molecular mechanisms of amisulpride- and risperidone-induced hPRL in patients with psychiatric disorders: an integrated approach combining network pharmacology and molecular docking.. Progress in neuro-psychopharmacology & biological psychiatry. https://doi.org/10.1016/j.pnpbp.2026.111974

Source records